Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Eytan M. Stein, Min Yang, Annie Guerin, Wei Gao, Philip Galebach, Cheryl Q. Xiang, Subrata Bhattacharyya, Gaetano Bonifacio, George J. Joseph

ABSTRACT

BACKGROUND: Preference valuations of health status are essential in health technology and economic appraisal. This study estimated utilities for treatment-related health states of acute myeloid leukemia (AML) and disutilities of severe adverse events (SAEs) using a representative sample of adults from the general population in the United States (US). METHODS: Treatment-related AML health states, defined based on literature and interviews with clinicians, included complete remission (CR), no CR, relapse, stem cell transplant (SCT), and post SCT short-term recovery. Six attributes with varying levels, including fever, lack of energy, problems with daily function, anxiety/depression, blood transfusions, and hospitalization, were used to define health states. An online survey using discrete choice experiment methodology was designed to capture preferences for health status scenarios including the identified attributes and key grade 3/4 chemotherapy-related SAEs. Health state utilities and SAE disutilities were generated from a conditional logistic regression with generalized estimating equations. RESULTS: Of the 300 survey participants, the demographic distributions were within a 3% margin of those in the 2010 US Census. CR had the highest utility value (0.875), followed by post-SCT short-term recovery (0.398), relapse (0.355), no CR (0.262), and SCT (0.158). Of the SAEs, serious infection had the highest decline in utility (0.218), followed by severe diarrhea (0.176), abnormally low blood cell counts (0.100), and severe redness/skin peeling (0.060). CONCLUSIONS: AML and treatments can result in reduced quality of life and impaired ability to perform daily activities. Findings of this study underline the value that society places on treatment-related AML health states and SAEs. More... »

PAGES

193

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12955-018-1013-9

DOI

http://dx.doi.org/10.1186/s12955-018-1013-9

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1107123531

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30241538


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Memorial Sloan Kettering Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Memorial Sloan Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stein", 
        "givenName": "Eytan M.", 
        "id": "sg:person.01076061725.68", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076061725.68"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Analysis Group (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417986.5", 
          "name": [
            "Analysis Group, Inc, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yang", 
        "givenName": "Min", 
        "id": "sg:person.01271427730.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271427730.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Analysis Group, Inc, Montreal, QC, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guerin", 
        "givenName": "Annie", 
        "id": "sg:person.01036633021.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036633021.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Analysis Group (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417986.5", 
          "name": [
            "Analysis Group, Inc, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gao", 
        "givenName": "Wei", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Analysis Group (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417986.5", 
          "name": [
            "Analysis Group, Inc, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Galebach", 
        "givenName": "Philip", 
        "id": "sg:person.0664463121.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664463121.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Analysis Group (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417986.5", 
          "name": [
            "Analysis Group, Inc, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Xiang", 
        "givenName": "Cheryl Q.", 
        "id": "sg:person.012516425013.86", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012516425013.86"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (India)", 
          "id": "https://www.grid.ac/institutes/grid.464975.d", 
          "name": [
            "Novartis Healthcare Pvt, Ltd, Hyderabad, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bhattacharyya", 
        "givenName": "Subrata", 
        "id": "sg:person.01261226053.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261226053.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418424.f", 
          "name": [
            "Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bonifacio", 
        "givenName": "Gaetano", 
        "id": "sg:person.011562221143.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011562221143.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novartis (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418424.f", 
          "name": [
            "Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joseph", 
        "givenName": "George J.", 
        "id": "sg:person.01366702602.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366702602.61"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/j.0006-341x.2001.00120.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001190289"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.0006-341x.2001.00120.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001190289"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2288-12-15", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003509075", 
          "https://doi.org/10.1186/1471-2288-12-15"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.socscimed.2014.05.026", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012078499"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40273-015-0292-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012727700", 
          "https://doi.org/10.1007/s40273-015-0292-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40273-015-0292-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012727700", 
          "https://doi.org/10.1007/s40273-015-0292-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11136-010-9639-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013824785", 
          "https://doi.org/10.1007/s11136-010-9639-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11136-010-9639-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013824785", 
          "https://doi.org/10.1007/s11136-010-9639-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12955-015-0377-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014095516", 
          "https://doi.org/10.1186/s12955-015-0377-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12955-014-0156-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014538997", 
          "https://doi.org/10.1186/s12955-014-0156-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12955-014-0156-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014538997", 
          "https://doi.org/10.1186/s12955-014-0156-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1477-7525-8-50", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017836267", 
          "https://doi.org/10.1186/1477-7525-8-50"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(12)61727-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017964639"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdr559", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020093926"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1524-4733.2009.00573.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020873197"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3324/haematol.2010.036715", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021069813"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1365-2141.1989.tb04253.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022340097"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4020-5753-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022634734", 
          "https://doi.org/10.1007/978-1-4020-5753-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4020-5753-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022634734", 
          "https://doi.org/10.1007/978-1-4020-5753-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2016.16786", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023308267"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2015-07-604538", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030741137"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2010.11.013", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030781921"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.2953", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033559468"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.328.7436.360", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036985070"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2012.08.2223", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037115565"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-10-182592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037803648"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/blood-2008-10-182592", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037803648"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jhealeco.2011.11.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039535015"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0305-7372(03)00142-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041462208"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0305-7372(03)00142-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041462208"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hec.3066", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041656275"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/17474086.2016.1211006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044656245"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1524-4733.2006.00108.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045708715"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jval.2016.04.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049866368"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.22233", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050295424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1182/asheducation-2012.1.43", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078659884"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ceor.s153286", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100618779"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "BACKGROUND: Preference valuations of health status are essential in health technology and economic appraisal. This study estimated utilities for treatment-related health states of acute myeloid leukemia (AML) and disutilities of severe adverse events (SAEs) using a representative sample of adults from the general population in the United States (US).\nMETHODS: Treatment-related AML health states, defined based on literature and interviews with clinicians, included complete remission (CR), no CR, relapse, stem cell transplant (SCT), and post SCT short-term recovery. Six attributes with varying levels, including fever, lack of energy, problems with daily function, anxiety/depression, blood transfusions, and hospitalization, were used to define health states. An online survey using discrete choice experiment methodology was designed to capture preferences for health status scenarios including the identified attributes and key grade 3/4 chemotherapy-related SAEs. Health state utilities and SAE disutilities were generated from a conditional logistic regression with generalized estimating equations.\nRESULTS: Of the 300 survey participants, the demographic distributions were within a 3% margin of those in the 2010 US Census. CR had the highest utility value (0.875), followed by post-SCT short-term recovery (0.398), relapse (0.355), no CR (0.262), and SCT (0.158). Of the SAEs, serious infection had the highest decline in utility (0.218), followed by severe diarrhea (0.176), abnormally low blood cell counts (0.100), and severe redness/skin peeling (0.060).\nCONCLUSIONS: AML and treatments can result in reduced quality of life and impaired ability to perform daily activities. Findings of this study underline the value that society places on treatment-related AML health states and SAEs.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12955-018-1013-9", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031326", 
        "issn": [
          "1477-7525"
        ], 
        "name": "Health and Quality of Life Outcomes", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States", 
    "pagination": "193", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "08c9648f213bf1e5e812f6c5950ef1f99e5c0a864155959b472fc79b2ec83abf"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30241538"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101153626"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12955-018-1013-9"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1107123531"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12955-018-1013-9", 
      "https://app.dimensions.ai/details/publication/pub.1107123531"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T14:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8660_00000605.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs12955-018-1013-9"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12955-018-1013-9'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12955-018-1013-9'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12955-018-1013-9'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12955-018-1013-9'


 

This table displays all metadata directly associated to this object as RDF triples.

231 TRIPLES      21 PREDICATES      59 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12955-018-1013-9 schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author N6aef41f39fb44b87b88fead39400e8c2
4 schema:citation sg:pub.10.1007/978-1-4020-5753-3
5 sg:pub.10.1007/s11136-010-9639-z
6 sg:pub.10.1007/s40273-015-0292-9
7 sg:pub.10.1186/1471-2288-12-15
8 sg:pub.10.1186/1477-7525-8-50
9 sg:pub.10.1186/s12955-014-0156-6
10 sg:pub.10.1186/s12955-015-0377-3
11 https://doi.org/10.1001/jama.2016.16786
12 https://doi.org/10.1002/cncr.22233
13 https://doi.org/10.1002/hec.2953
14 https://doi.org/10.1002/hec.3066
15 https://doi.org/10.1016/j.jhealeco.2011.11.004
16 https://doi.org/10.1016/j.jval.2010.11.013
17 https://doi.org/10.1016/j.jval.2012.08.2223
18 https://doi.org/10.1016/j.jval.2016.04.004
19 https://doi.org/10.1016/j.socscimed.2014.05.026
20 https://doi.org/10.1016/s0140-6736(12)61727-9
21 https://doi.org/10.1016/s0305-7372(03)00142-7
22 https://doi.org/10.1080/17474086.2016.1211006
23 https://doi.org/10.1093/annonc/mdr559
24 https://doi.org/10.1111/j.0006-341x.2001.00120.x
25 https://doi.org/10.1111/j.1365-2141.1989.tb04253.x
26 https://doi.org/10.1111/j.1524-4733.2006.00108.x
27 https://doi.org/10.1111/j.1524-4733.2009.00573.x
28 https://doi.org/10.1136/bmj.328.7436.360
29 https://doi.org/10.1182/asheducation-2012.1.43
30 https://doi.org/10.1182/blood-2008-10-182592
31 https://doi.org/10.1182/blood-2015-07-604538
32 https://doi.org/10.2147/ceor.s153286
33 https://doi.org/10.3324/haematol.2010.036715
34 schema:datePublished 2018-12
35 schema:datePublishedReg 2018-12-01
36 schema:description BACKGROUND: Preference valuations of health status are essential in health technology and economic appraisal. This study estimated utilities for treatment-related health states of acute myeloid leukemia (AML) and disutilities of severe adverse events (SAEs) using a representative sample of adults from the general population in the United States (US). METHODS: Treatment-related AML health states, defined based on literature and interviews with clinicians, included complete remission (CR), no CR, relapse, stem cell transplant (SCT), and post SCT short-term recovery. Six attributes with varying levels, including fever, lack of energy, problems with daily function, anxiety/depression, blood transfusions, and hospitalization, were used to define health states. An online survey using discrete choice experiment methodology was designed to capture preferences for health status scenarios including the identified attributes and key grade 3/4 chemotherapy-related SAEs. Health state utilities and SAE disutilities were generated from a conditional logistic regression with generalized estimating equations. RESULTS: Of the 300 survey participants, the demographic distributions were within a 3% margin of those in the 2010 US Census. CR had the highest utility value (0.875), followed by post-SCT short-term recovery (0.398), relapse (0.355), no CR (0.262), and SCT (0.158). Of the SAEs, serious infection had the highest decline in utility (0.218), followed by severe diarrhea (0.176), abnormally low blood cell counts (0.100), and severe redness/skin peeling (0.060). CONCLUSIONS: AML and treatments can result in reduced quality of life and impaired ability to perform daily activities. Findings of this study underline the value that society places on treatment-related AML health states and SAEs.
37 schema:genre research_article
38 schema:inLanguage en
39 schema:isAccessibleForFree true
40 schema:isPartOf N540c06cbed2442da938a64d1541eea5e
41 Na1a5ed62be4747fba98cf32ba2645ca6
42 sg:journal.1031326
43 schema:name Assessing utility values for treatment-related health states of acute myeloid leukemia in the United States
44 schema:pagination 193
45 schema:productId N0f08ae8f95884a37901a4125fb8e96fe
46 N165902c3c4374575993c3dee0b280889
47 N72876985e16046acb949911bef397c8f
48 Nafe3c1a0a9c44da7a46a00e108bf22ec
49 Nc40601bf3fb54fa7ab25882db3dd8f11
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1107123531
51 https://doi.org/10.1186/s12955-018-1013-9
52 schema:sdDatePublished 2019-04-10T14:24
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher Nc99d25c9f3b34337a5408dac10d0235f
55 schema:url http://link.springer.com/10.1186%2Fs12955-018-1013-9
56 sgo:license sg:explorer/license/
57 sgo:sdDataset articles
58 rdf:type schema:ScholarlyArticle
59 N0ae11d2ca6884aed9fa5f379502ba064 rdf:first sg:person.011562221143.72
60 rdf:rest N2fae65d466c043009417f94163a22480
61 N0f08ae8f95884a37901a4125fb8e96fe schema:name nlm_unique_id
62 schema:value 101153626
63 rdf:type schema:PropertyValue
64 N165902c3c4374575993c3dee0b280889 schema:name pubmed_id
65 schema:value 30241538
66 rdf:type schema:PropertyValue
67 N24bec3dcb9704d37b63cfd3be9a4a47e rdf:first sg:person.0664463121.42
68 rdf:rest N973e5e79306d496b95a06d018773fa6c
69 N29145395ff1f4f4481ad7c241176e862 rdf:first sg:person.01271427730.47
70 rdf:rest N9cf68d6967eb4ff480d0678099b9adab
71 N2fae65d466c043009417f94163a22480 rdf:first sg:person.01366702602.61
72 rdf:rest rdf:nil
73 N540c06cbed2442da938a64d1541eea5e schema:issueNumber 1
74 rdf:type schema:PublicationIssue
75 N5501a1e9fbe84de698efacea1b4f9f2d rdf:first sg:person.01261226053.01
76 rdf:rest N0ae11d2ca6884aed9fa5f379502ba064
77 N6aef41f39fb44b87b88fead39400e8c2 rdf:first sg:person.01076061725.68
78 rdf:rest N29145395ff1f4f4481ad7c241176e862
79 N72876985e16046acb949911bef397c8f schema:name dimensions_id
80 schema:value pub.1107123531
81 rdf:type schema:PropertyValue
82 N738bfe9584924e5aaebef1eba3523efb rdf:first Ne1edb131cae1426287ce3ad8c4102683
83 rdf:rest N24bec3dcb9704d37b63cfd3be9a4a47e
84 N973e5e79306d496b95a06d018773fa6c rdf:first sg:person.012516425013.86
85 rdf:rest N5501a1e9fbe84de698efacea1b4f9f2d
86 N9cf68d6967eb4ff480d0678099b9adab rdf:first sg:person.01036633021.78
87 rdf:rest N738bfe9584924e5aaebef1eba3523efb
88 Na1a5ed62be4747fba98cf32ba2645ca6 schema:volumeNumber 16
89 rdf:type schema:PublicationVolume
90 Nafe3c1a0a9c44da7a46a00e108bf22ec schema:name doi
91 schema:value 10.1186/s12955-018-1013-9
92 rdf:type schema:PropertyValue
93 Nc32a9e22cfe34d29b3374b57dc51dc9c schema:name Analysis Group, Inc, Montreal, QC, Canada
94 rdf:type schema:Organization
95 Nc40601bf3fb54fa7ab25882db3dd8f11 schema:name readcube_id
96 schema:value 08c9648f213bf1e5e812f6c5950ef1f99e5c0a864155959b472fc79b2ec83abf
97 rdf:type schema:PropertyValue
98 Nc99d25c9f3b34337a5408dac10d0235f schema:name Springer Nature - SN SciGraph project
99 rdf:type schema:Organization
100 Ne1edb131cae1426287ce3ad8c4102683 schema:affiliation https://www.grid.ac/institutes/grid.417986.5
101 schema:familyName Gao
102 schema:givenName Wei
103 rdf:type schema:Person
104 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
105 schema:name Medical and Health Sciences
106 rdf:type schema:DefinedTerm
107 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
108 schema:name Public Health and Health Services
109 rdf:type schema:DefinedTerm
110 sg:journal.1031326 schema:issn 1477-7525
111 schema:name Health and Quality of Life Outcomes
112 rdf:type schema:Periodical
113 sg:person.01036633021.78 schema:affiliation Nc32a9e22cfe34d29b3374b57dc51dc9c
114 schema:familyName Guerin
115 schema:givenName Annie
116 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036633021.78
117 rdf:type schema:Person
118 sg:person.01076061725.68 schema:affiliation https://www.grid.ac/institutes/grid.51462.34
119 schema:familyName Stein
120 schema:givenName Eytan M.
121 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01076061725.68
122 rdf:type schema:Person
123 sg:person.011562221143.72 schema:affiliation https://www.grid.ac/institutes/grid.418424.f
124 schema:familyName Bonifacio
125 schema:givenName Gaetano
126 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011562221143.72
127 rdf:type schema:Person
128 sg:person.012516425013.86 schema:affiliation https://www.grid.ac/institutes/grid.417986.5
129 schema:familyName Xiang
130 schema:givenName Cheryl Q.
131 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012516425013.86
132 rdf:type schema:Person
133 sg:person.01261226053.01 schema:affiliation https://www.grid.ac/institutes/grid.464975.d
134 schema:familyName Bhattacharyya
135 schema:givenName Subrata
136 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01261226053.01
137 rdf:type schema:Person
138 sg:person.01271427730.47 schema:affiliation https://www.grid.ac/institutes/grid.417986.5
139 schema:familyName Yang
140 schema:givenName Min
141 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01271427730.47
142 rdf:type schema:Person
143 sg:person.01366702602.61 schema:affiliation https://www.grid.ac/institutes/grid.418424.f
144 schema:familyName Joseph
145 schema:givenName George J.
146 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01366702602.61
147 rdf:type schema:Person
148 sg:person.0664463121.42 schema:affiliation https://www.grid.ac/institutes/grid.417986.5
149 schema:familyName Galebach
150 schema:givenName Philip
151 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0664463121.42
152 rdf:type schema:Person
153 sg:pub.10.1007/978-1-4020-5753-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022634734
154 https://doi.org/10.1007/978-1-4020-5753-3
155 rdf:type schema:CreativeWork
156 sg:pub.10.1007/s11136-010-9639-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1013824785
157 https://doi.org/10.1007/s11136-010-9639-z
158 rdf:type schema:CreativeWork
159 sg:pub.10.1007/s40273-015-0292-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012727700
160 https://doi.org/10.1007/s40273-015-0292-9
161 rdf:type schema:CreativeWork
162 sg:pub.10.1186/1471-2288-12-15 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003509075
163 https://doi.org/10.1186/1471-2288-12-15
164 rdf:type schema:CreativeWork
165 sg:pub.10.1186/1477-7525-8-50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017836267
166 https://doi.org/10.1186/1477-7525-8-50
167 rdf:type schema:CreativeWork
168 sg:pub.10.1186/s12955-014-0156-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014538997
169 https://doi.org/10.1186/s12955-014-0156-6
170 rdf:type schema:CreativeWork
171 sg:pub.10.1186/s12955-015-0377-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014095516
172 https://doi.org/10.1186/s12955-015-0377-3
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1001/jama.2016.16786 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023308267
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1002/cncr.22233 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050295424
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1002/hec.2953 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033559468
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1002/hec.3066 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041656275
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1016/j.jhealeco.2011.11.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039535015
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1016/j.jval.2010.11.013 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030781921
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/j.jval.2012.08.2223 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037115565
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/j.jval.2016.04.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049866368
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/j.socscimed.2014.05.026 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012078499
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/s0140-6736(12)61727-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017964639
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/s0305-7372(03)00142-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041462208
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1080/17474086.2016.1211006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044656245
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1093/annonc/mdr559 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020093926
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1111/j.0006-341x.2001.00120.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1001190289
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1111/j.1365-2141.1989.tb04253.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1022340097
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1111/j.1524-4733.2006.00108.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1045708715
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1111/j.1524-4733.2009.00573.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1020873197
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1136/bmj.328.7436.360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036985070
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1182/asheducation-2012.1.43 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078659884
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1182/blood-2008-10-182592 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037803648
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1182/blood-2015-07-604538 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030741137
215 rdf:type schema:CreativeWork
216 https://doi.org/10.2147/ceor.s153286 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100618779
217 rdf:type schema:CreativeWork
218 https://doi.org/10.3324/haematol.2010.036715 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021069813
219 rdf:type schema:CreativeWork
220 https://www.grid.ac/institutes/grid.417986.5 schema:alternateName Analysis Group (United States)
221 schema:name Analysis Group, Inc, Boston, MA, USA
222 rdf:type schema:Organization
223 https://www.grid.ac/institutes/grid.418424.f schema:alternateName Novartis (United States)
224 schema:name Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
225 rdf:type schema:Organization
226 https://www.grid.ac/institutes/grid.464975.d schema:alternateName Novartis (India)
227 schema:name Novartis Healthcare Pvt, Ltd, Hyderabad, India
228 rdf:type schema:Organization
229 https://www.grid.ac/institutes/grid.51462.34 schema:alternateName Memorial Sloan Kettering Cancer Center
230 schema:name Memorial Sloan Kettering Cancer Center, New York, NY, USA
231 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...